By proceeding, you agree to our Terms of Use and Privacy Policy.
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. We aim to meet your research needs.
Visit numerous concurrent sessions for informative presentations, lively dialogues, and meaningful connections with fully vaccinated peers.
Customize your experience further through courses, interactive discussions, and networking options that will help you engage with experts and solutions providers.
The event brings back popular topics like PROTACs and RNA plus new programming on immunomodulation, antivirals, neurodegeneration targets, KRAS, and AI.
Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
At Charles River, we are passionate about our role in improving the quality of people’s lives.
Reaction Biology provides pre-clinical drug discovery solutions as your trusted partner.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients.
Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow.
Fluidic Analytics – Understand the Machinery of Life.
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands.
Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA.
Founded in 1995 by Dr Philippe Genne, the Company’s CEO and Chairman, Oncodesign is a biopharma company dedicated to the precision medicine.
Collaborative Drug Discovery's CDD VAULT is a hosted biological and chemical database that securely manages your private and external data.
BPS manufactures one of the largest selections of recombinant enzymes, neutralizing antibodies, inhibitor assay kits, lentiviruses and cell lines for drug discovery and continues to expand its drug discovery products.
Horizon Discovery, a PerkinElmer company, drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the
Curi Bio is accelerating the discovery of the next generation of medicines by integrating human cells, systems, and data.
Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. The product is called RepliGut.
Biosensing Instrument is a life science company that designs and supplies award winning label-free molecular interaction instruments based on the Surface Plasmon Resonance technology.
Carterra is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates.
Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets.
Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally.
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, and transporters.
We are committed to providing pure, high-quality indicators to empower better research results for basic and translational research. Our vision is to create new and innovative discovery tools for scientists across all fields of cell research.
Our goal is to produce fast and innovative solutions to global pharmaceutical and specialty chemical companies within the space of contract research, development and manufacturing.
Multispan, Inc. is a premier assay screening technology provider targeting GPCRs, kinases and beyond using endogenously expressed targets in primary cells and recombinant stable cell lines.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.